Silkothane Arteriovenous Graft
Hybrid silk fibroin–polyurethane graft for hemodialysis access
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Silkothane® Arteriovenous Graft is Dialybrid’s lead clinical-stage product: a partially resorbable arteriovenous graft made from Silkothane®, a patented hybrid of silk fibroin and polyurethane produced via electrospinning. Public materials describe goals of faster cannulation than native fistulas and improved durability versus conventional synthetic grafts. A first-in-human pilot study in Italy began enrollment in 2026 after a €15 million Series A to fund clinical development. Product page: dialybrid.com/technology/.
- Website
- dialybrid.com/technology
- Added via
- web
- Ownership
- unclaimed